IP Library › Assignment 015680/0399
Patent Assignment
Reel/Frame 015680/0399

Assignment of Assignor's Interest

Recorded: 2004-08-16 Pages: 2
Assignors
WEBER, ECKARD
Executed: 2004-08-01
COWLEY, MICHAEL ALEXANDER
Executed: 2004-07-19
Assignee
OREXIGEN THERAPUTICS, INC.
ONE PALMER SQUARE, SUITE 515, PRINCETON, NEW JERSEY, 08540
Covered Property (1)
Compositions for Affecting Weight Loss
Patent: 7,375,111 →
Application: 10/828,795 →
Publication: US 2004/0254208
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest Aug 2, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 046688/0661 →
Security Interest Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →